Literature DB >> 25040790

Norovirus infection in immunocompromised hosts.

K Y Green1.   

Abstract

Acute gastroenteritis caused by noroviruses often has a duration of 2-3 days and is characteristically self-limiting. In contrast, chronic infection caused by noroviruses in immunocompromised individuals can last from weeks to years, making clinical management difficult. The mechanisms by which noroviruses establish persistent infection, and the role of immunocompromised hosts as a reservoir for noroviruses in the general human population, are not known. However, study of this patient cohort may lead to new insights into norovirus biology and approaches to treatment.
© 2014 The Author Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Acquired immunodeficiency; chronic infection; immunocompromised; immunosuppressed; norovirus

Mesh:

Year:  2014        PMID: 25040790     DOI: 10.1111/1469-0691.12761

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  48 in total

Review 1.  Emergence of norovirus strains: A tale of two genes.

Authors:  Gabriel I Parra
Journal:  Virus Evol       Date:  2019-11-25

2.  Norovirus Loads in Stool Specimens of Cancer Patients with Norovirus Gastroenteritis.

Authors:  Taojun He; Tracy A McMillen; Yuanyuan Qiu; Liang Hua Chen; Xuedong Lu; Xiao-Li Pang; Mini Kamboj; Yi-Wei Tang
Journal:  J Mol Diagn       Date:  2017-08-12       Impact factor: 5.568

3.  Generation of Norovirus-Specific T Cells From Human Donors With Extensive Cross-Reactivity to Variant Sequences: Implications for Immunotherapy.

Authors:  Ryo Hanajiri; Gelina M Sani; Devin Saunders; Patrick J Hanley; Abha Chopra; Simon A Mallal; Stanislav V Sosnovtsev; Jeffrey I Cohen; Kim Y Green; Catherine M Bollard; Michael D Keller
Journal:  J Infect Dis       Date:  2020-02-03       Impact factor: 5.226

4.  Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients.

Authors:  Umesh C Karandikar; Sue E Crawford; Nadim J Ajami; Kosuke Murakami; Baijun Kou; Khalil Ettayebi; Genovefa A Papanicolaou; Ubonvan Jongwutiwes; Miguel-Angel Perales; Jinru Shia; David Mercer; Milton J Finegold; Jan Vinjé; Robert L Atmar; Mary K Estes
Journal:  J Gen Virol       Date:  2016-07-12       Impact factor: 3.891

5.  Norovirus in health care and implications for the immunocompromised host.

Authors:  Pearlie P Chong; Robert L Atmar
Journal:  Curr Opin Infect Dis       Date:  2019-08       Impact factor: 4.915

6.  Chronic norovirus infection in a patient with a past history of Burkitt lymphoma.

Authors:  Leesa D Bruggink; Lachlan Hayes; John A Marshall
Journal:  Virusdisease       Date:  2015-08-20

Review 7.  Chronic norovirus infection and common variable immunodeficiency.

Authors:  J Woodward; E Gkrania-Klotsas; D Kumararatne
Journal:  Clin Exp Immunol       Date:  2016-11-16       Impact factor: 4.330

8.  Replication of human noroviruses in stem cell-derived human enteroids.

Authors:  Khalil Ettayebi; Sue E Crawford; Kosuke Murakami; James R Broughman; Umesh Karandikar; Victoria R Tenge; Frederick H Neill; Sarah E Blutt; Xi-Lei Zeng; Lin Qu; Baijun Kou; Antone R Opekun; Douglas Burrin; David Y Graham; Sasirekha Ramani; Robert L Atmar; Mary K Estes
Journal:  Science       Date:  2016-08-25       Impact factor: 47.728

9.  Identification of a norovirus outbreak on a hematopoietic stem cell transplant unit and development and implementation of a novel infection prevention algorithm for controlling transmission.

Authors:  Westyn Branch-Elliman; Roger V Araujo-Castillo; Graham M Snyder; Bernadette F Sullivan; Carolyn D Alonso; Sharon B Wright
Journal:  Infect Control Hosp Epidemiol       Date:  2020-02-24       Impact factor: 3.254

Review 10.  Recent Advances in the Discovery of Norovirus Therapeutics.

Authors:  Yunjeong Kim; Anushka C Galasiti Kankanamalage; Kyeong-Ok Chang; William C Groutas
Journal:  J Med Chem       Date:  2015-08-17       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.